Craft

Medistim

Stock Price

KR167.5

2024-10-29

Market Capitalization

KR3.1 B

2024-10-29

Revenue

KR699.8 M

FY, 2025

Medistim Summary

Company Summary

Overview
Medistim is involved in intraoperative ultrasonic guidance and quality assessment focused on improving surgical outcomes. With the MiraQ platform, Medistim offers the unique combination of transit time flow measurement (TTFM) and high-frequency ultrasound imaging. The Company provides quality control applications for use in the operating theatre during cardiac and vascular surgery.
Type
Public
Status
Active
Founded
1984
HQ
Oslo, NO | view all locations
Website
http://www.medistim.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Øyvin A. Brøymer, Chairman

    • Lars Rønn, Director

      • Torben Jörgensen, Deputy Chairman

        • Siri Fürst, Director

          LocationsView all

          6 locations detected

          • Oslo, Oslo HQ

            Norway

            Økernveien 94

          • Plymouth, MN

            United States

            14000 25th Ave N

          • Ringsted

            Denmark

            Søgade 16

          • Oberhaching, BY

            Germany

            Bahnhofstraße 32

          • Barcelona, CT

            Spain

            Carrer de Balmes, 173, 4, 2

          • West Bridgford, England

            United Kingdom

            Vermont House, 5 Wilford Rd

          Medistim Financials

          Summary Financials

          Revenue (FY, 2025)
          kr699.8M
          Gross profit (FY, 2025)
          kr571.6M
          Net income (FY, 2025)
          kr159.2M
          Cash (FY, 2025)
          kr206.2M
          EBIT (FY, 2025)
          kr196.2M
          Enterprise value
          $3.0B

          Footer menu